Skip to main content
ARS Home » Midwest Area » Peoria, Illinois » National Center for Agricultural Utilization Research » Renewable Product Technology Research » Research » Publications at this Location » Publication #326719

Research Project: Technologies for Producing Renewable Bioproducts

Location: Renewable Product Technology Research

Title: Modification of the mannitol biosynthetic pathway in Aureobasidium pullulans to alter the structure of the polyol lipid liamocin

item Skory, Christopher - Chris
item Price, Neil
item Leathers, Timothy
item Hector, Ronald - Ron
item Bowman, Michael
item Rich, Joseph

Submitted to: Meeting Abstract
Publication Type: Abstract Only
Publication Acceptance Date: 3/1/2016
Publication Date: 7/28/2016
Citation: Skory, C.D., Price, N.P.J., Leathers, T.D., Manitchotpisit, P., Hector, R.E., Bowman, M.J., Rich, J.O. 2016. Modification of the mannitol biosynthetic pathway in Aureobasidium pullulans to alter the structure of the polyol lipid liamocin [abstract]. Society for Industrial Microbiology and Biotechnology. Poster P39, Paper 32487.

Interpretive Summary:

Technical Abstract: Aureobasidium pullulans is an important industrial organism that is utilized for the production of numerous bioproducts, such as pullulan, ß-glucan, aureobasidin, and polymalic acid. Our laboratory is also interested in production of the extracellular polyol lipids, called liamocins, produced by certain isolates of A. pullulans under nitrogen limiting conditions. Liamocins are comprised of a polyol head group that is ester-linked at one end to a 3, 5-dihydroxydecanoic acid, which is sequentially coupled to several other 3, 5-dihydroxydecanoic acid groups. Mannitol headgroups are usually the predominant structure when glucose, fructose, sucrose, or xylose is used as the carbon source, but some A. pullulans strains produce liamocins that are up to 40% arabitol-containing structures. We have shown that liamocins have biosurfactant properties and differentially inhibited mammalian cancer cell lines. Most recently, we determined that these microbial oils have potent selective antibacterial activities against certain Gram positive organisms that are important in veterinary and clinical medicine. The inhibitory properties of liamocins are partly influenced by the type of polyol head group, so we developed methods to alter the mannitol biosynthetic pathway to better control the type of liamocin produced. Deletion of the mannitol 1-phosphate dehydrogenase shifted intracellular accumulation of mannitol to arabitol when strains were grown on glucose. Further deletion of the mannitol dehydrogenase gene eliminated both polyols regardless of whether cells were grown in glucose or fructose. As a result, the modified Aureobasidium strains could be utilized to secrete exclusively arabitol-containing liamocin.